2007
DOI: 10.1002/ejoc.200700082
|View full text |Cite
|
Sign up to set email alerts
|

Recent Progress in Asymmetric Catalysis Using Chiral Carbohydrate‐Based Ligands

Abstract: This review describes the use of the most representative carbohydrate derivative ligands in asymmetric catalysis between 1972 and 2006 (approximately). Particular emphasis is placed on the latest results published in the most active period of this area of research (1998 to January 2007). In the first sections we cover the results obtained using homodonor ligands, such as phosphanes, phosphinites, phosphites and dithioethers. In the next sections, we present the results of using heterodonor ligands, such as P–P… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
15
0
1

Year Published

2009
2009
2019
2019

Publication Types

Select...
6
3

Relationship

2
7

Authors

Journals

citations
Cited by 96 publications
(16 citation statements)
references
References 102 publications
0
15
0
1
Order By: Relevance
“…Recently, carbohydrates and their derivatives have emerged as an important tool for selective synthesis and as a chiral pool for the design of chiral ligands. They are used as chiral building blocks, precursors for drug synthesis and chiral catalysts in asymmetric catalysis (Dieguez et al, 2004a(Dieguez et al, , 2004b(Dieguez et al, , 2007Woodward et al, 2010;Boysen, 2007;Appelt et al, 2008). Despite the importance of carbohydrates in biological events, the pace of development of carbohydrate based therapeutics has been relatively slow.…”
Section: Resultsmentioning
confidence: 99%
“…Recently, carbohydrates and their derivatives have emerged as an important tool for selective synthesis and as a chiral pool for the design of chiral ligands. They are used as chiral building blocks, precursors for drug synthesis and chiral catalysts in asymmetric catalysis (Dieguez et al, 2004a(Dieguez et al, , 2004b(Dieguez et al, , 2007Woodward et al, 2010;Boysen, 2007;Appelt et al, 2008). Despite the importance of carbohydrates in biological events, the pace of development of carbohydrate based therapeutics has been relatively slow.…”
Section: Resultsmentioning
confidence: 99%
“…Two pyrene‐tagged diphosphite ligands were obtained following the procedure depicted in Scheme . First, the commercially available 1,2,5,6‐di‐isopropylideneglucofuranose ( 7 ) was treated with N‐bromosuccinimide and triphenylphosphine to provide the corresponding 6‐bromo derivative 8 followed by sodium nitrite treatment yielding the corresponding alcohol 9 ,. The alkylation of 9 was performed by reaction with either 1‐(bromomethyl)pyrene to afford 10 in 73 % yield, or with the freshly synthesised 4‐(pyren‐2‐yl)butyl trifluoromethanesulfonate affording 11 in 55 % yield.…”
Section: Resultsmentioning
confidence: 99%
“…These compounds were characterised by means of multinuclear NMR spectroscopy and MS. It is noteworthy that compared to the synthesis of the analogous ligand 4 a ,, no extra synthetic steps were required to prepare the pyrene tagged ligands 14 a and 15 a .…”
Section: Resultsmentioning
confidence: 99%
“…It is worth mentioning that carbohydrates and some basic amino acids are the most bio‐abundant groups of molecules that have environmentally benign natures and can provide promising cost benefits for industrial processes, and this is why they have high potential for use in various synthetic applications. Chemists are using these very often as the main precursors in the synthesis of natural compounds and pharmaceutically important drugs, while significant progress has been made in the field of selective catalytic reactions, where they have important roles as efficient bio‐based ligands …”
Section: Resultsmentioning
confidence: 99%